Strategic Partners
Creating maximum value for our nexus by building strategic partnerships and collaborations with key organizations across the entire drug development value chain
Preclinical CRO
Axis Bio is a full suite preclinical contract research organization with specialist capabilities in oncology, inflammation and respiratory diseases
Established strategic alliance underscores our shared commitment for innovation and patient-centered drug development in an efficient and streamlined fashion focused on critical non-clinical IND-enabling drug development activities including, but not limited to, pharmacokinetic, pharmacodynamic, safety/toxicology, and early efficacy studies
Target engagement and physiopathology candidate profiling solutions
G.CLIPS Biotech is a technology platform company changing the paradigm in targets by enabling the discovery, generation and validation of conformation-sensitive and pathology-sensitive drug candidates.
This partnership addresses a critical gap in early-stage drug development, where target engagement and physiopathology – a cornerstone of therapeutic efficacy and safety – is often underestimated, due to technical, financial and/or strategic constraints. Addressing this gap early helps to de-risk the overall drug development process, gaining significant efficiencies, with both time and cost savings.
High Performance Incubator for Healthcare Startups
Quest for Health is a health incubator strategically located in the heart of Europe in the Grand Est region, at the crossroads of Switzerland, Germany and France, an area at the cutting edge of healthcare innovation
Strategic and operational partnership established as a launching point for our BioVentures Excellence Program designed to help startups master “Smarter Strategy, Superior Execution” in a biotech start up context where we help strengthen projects, enhance strategic positioning, and connect with a committed community of experts and entrepreneurs
